Technology | Treatment Planning | August 15, 2017

French company achieves CE Mark for treatment planning system for modeling and computing dose distributions with double scattering beams and pencil beam scanning

DOSIsoft Releases ISOgray Proton Therapy Treatment Planning System

August 15, 2017 — DOSIsoft SA announced the official release, with CE marking, of ISOgray Treatment Planning System (TPS) release 4.3 for proton therapy with active scanning beams (pencil beam scanning). The milestone was achieved through close collaboration with Institut Curie - Protontherapy Center of Orsay (ICPO) in France.

Due to the high energy of proton beams and specific dose deposit phenomena, proton therapy planning requires particular dose computation accuracy for dealing with uncertainties, according to the dose delivery technique.

ISOgray-Proton software is now available for modeling and computing dose distributions with double scattering beams and pencil beam scanning (PBS) technologies of IBA proton radiotherapy treatment machines.

The latest development offers new features such as:

  • Single Field Uniform Dose (SFUD) optimization to deliver a uniform dose per field in a target volume; and
  • Exacor module used to carry out PBS verification plans as well as to compare the results obtained with measurements from various detectors (e.g., IBA-MatriXX).

Robust optimization algorithms based on the Pencil Beam Kernel dose calculation model are available with user-friendly interface to offer highly conformal treatments. 

In the context of a modernization project of its center begun in 2010, ICPO near Paris, France and DOSIsoft have been collaborating actively since then for new algorithm implementation and joint research activities.

“As the first center in France to implement ISOgray-Proton, ICPO confirms the promising results from the partnership. This proton therapy planning technology offers new modalities to facilitate the treatment of tumors situated near important organs and structures like cranial base tumors.” commented Ludovic De Marzi, medical physicist at ICPO.

Read the related article "Imaging Considerations for Proton Therapy Treatment Planning."
 

 

For more information: www.dosisoft.com


Related Content

News

Aug. 5, 2024 — Researchers from The University of Texas MD Anderson Cancer Center have demonstrated that adding ...

Time August 09, 2024
arrow
News | PET-CT

July 31, 2024 — In a head-to-head comparison with FDG PET/CT, FDG PET/MRI demonstrated comparable or superior diagnostic ...

Time July 31, 2024
arrow
Feature | Radiation Oncology | By Christine Book

News emerging from several leading organizations and vendors in the radiation therapy arena came in at a fast pace in ...

Time July 30, 2024
arrow
News | Radiation Oncology

July 11, 2024 — The American Society for Radiation Oncology (ASTRO) issued the following statement from Jeff M ...

Time July 11, 2024
arrow
News | Radiation Oncology

July 9, 2024 — Insights from the latest Mordor Intelligence report, “Radiotherapy Market Size & Share Analysis - Growth ...

Time July 09, 2024
arrow
News | Prostate Cancer

July 5, 2024 — Lantheus Holdings, Inc., a leading radiopharmaceutical-focused company committed to enabling clinicians ...

Time July 05, 2024
arrow
News | Radiology Business

July 3, 2024 — The American Society of Radiologic Technologists has launched the BeRAD Professionalism Award to ...

Time July 03, 2024
arrow
News | Prostate Cancer

July 2, 2024 — A new editorial paper was published in Oncoscience (Volume 11) on May 20, 2024, entitled, “Deep learning ...

Time July 02, 2024
arrow
News | Radiation Therapy

June 19, 2024 — RaySearch Laboratories AB announced a milestone in radiotherapy technology where RaySearch’s RayStation ...

Time June 19, 2024
arrow
News | Radiation Oncology

June 3, 2024 — The American Society for Radiation Oncology (ASTRO) published an updated clinical guideline that details ...

Time June 03, 2024
arrow
Subscribe Now